{"id":"W2908768956","doi":"10.1136/rmdopen-2018-000806","title":"Tofacitinib or adalimumab versus placebo: patient-reported outcomes from OPAL Broaden—a phase III study of active psoriatic arthritis in patients with an inadequate response to conventional synthetic disease-modifying antirheumatic drugs","year":2019,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"","keywords":"Medicine; Tofacitinib; Adalimumab; Minimal clinically important difference; Placebo; Psoriatic arthritis; Ankylosing spondylitis; Internal medicine; Janus kinase inhibitor; Quality of life (healthcare); Physical therapy; Arthritis; Rheumatoid arthritis; Randomized controlled trial; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002341753,0.0003480697,0.001071876,0.0002205976,0.0001244061,0.00006063882,0.0002260034,0.00005355775,0.0006577369],"category_scores_gemma":[0.0003579934,0.0002690692,0.00007987062,0.0003298195,0.00005133293,0.0003638706,0.0002519063,0.0001435386,0.00004113803],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002487308,"about_ca_system_score_gemma":0.0002424764,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002845445,"about_ca_topic_score_gemma":0.0008359872,"domain_scores_codex":[0.9970376,0.0003080832,0.0008162912,0.00066496,0.0007896844,0.0003834182],"domain_scores_gemma":[0.9980141,0.0004623027,0.0003995469,0.0006465669,0.0001669713,0.0003105385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.6276047,0.01088439,0.2882369,0.00005211772,0.001329001,0.0004572156,0.01147806,0.00002806104,0.00001249215,0.000005015829,0.00001223472,0.05989988],"study_design_scores_gemma":[0.3946688,0.01537564,0.5752547,0.001201314,0.0003380271,0.000002796913,0.01268647,0.00007284149,0.00004198135,0.00001260377,0.00004092256,0.0003038748],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918681,0.00004629931,0.000001759835,0.00009193351,0.0002842255,0.007073071,0.0005154212,0.00002688022,0.00009235645],"genre_scores_gemma":[0.998834,0.000009369168,0.000173615,0.00005465231,0.000008533624,0.0004227215,0.0003442156,0.0000462051,0.0001067629],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2870179,"threshold_uncertainty_score":0.9999762,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03191572517226805,"score_gpt":0.3292522620125296,"score_spread":0.2973365368402616,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}